Literature DB >> 35624212

Mapping the tumor-infiltrating immune cells during glioblastoma progression.

Senthilnath Lakshmanachetty1, Siddhartha S Mitra2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35624212     DOI: 10.1038/s41590-022-01223-0

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   31.250


× No keyword cloud information.
  8 in total

1.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Authors:  Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

2.  Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression.

Authors:  Alan T Yeo; Shruti Rawal; Bethany Delcuze; Anthos Christofides; Agata Atayde; Laura Strauss; Leonora Balaj; Vaughn A Rogers; Erik J Uhlmann; Hemant Varma; Bob S Carter; Vassiliki A Boussiotis; Al Charest
Journal:  Nat Immunol       Date:  2022-05-27       Impact factor: 31.250

3.  Microglia in the Brain Tumor Microenvironment.

Authors:  Allison P Cole; Eric Hoffmeyer; Senthilnath Lakshmana Chetty; Joselyn Cruz-Cruz; Forrest Hamrick; Osama Youssef; Samuel Cheshier; Siddhartha S Mitra
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.

Authors:  Cyril Neftel; Julie Laffy; Mariella G Filbin; Toshiro Hara; Marni E Shore; Gilbert J Rahme; Alyssa R Richman; Dana Silverbush; McKenzie L Shaw; Christine M Hebert; John Dewitt; Simon Gritsch; Elizabeth M Perez; L Nicolas Gonzalez Castro; Xiaoyang Lan; Nicholas Druck; Christopher Rodman; Danielle Dionne; Alexander Kaplan; Mia S Bertalan; Julia Small; Kristine Pelton; Sarah Becker; Dennis Bonal; Quang-De Nguyen; Rachel L Servis; Jeremy M Fung; Ravindra Mylvaganam; Lisa Mayr; Johannes Gojo; Christine Haberler; Rene Geyeregger; Thomas Czech; Irene Slavc; Brian V Nahed; William T Curry; Bob S Carter; Hiroaki Wakimoto; Priscilla K Brastianos; Tracy T Batchelor; Anat Stemmer-Rachamimov; Maria Martinez-Lage; Matthew P Frosch; Ivan Stamenkovic; Nicolo Riggi; Esther Rheinbay; Michelle Monje; Orit Rozenblatt-Rosen; Daniel P Cahill; Anoop P Patel; Tony Hunter; Inder M Verma; Keith L Ligon; David N Louis; Aviv Regev; Bradley E Bernstein; Itay Tirosh; Mario L Suvà
Journal:  Cell       Date:  2019-07-18       Impact factor: 41.582

Review 5.  New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs.

Authors:  Senthilnath Lakshmanachetty; Joselyn Cruz-Cruz; Eric Hoffmeyer; Allison P Cole; Siddhartha S Mitra
Journal:  Cells       Date:  2021-04-14       Impact factor: 6.600

6.  Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response.

Authors:  Kevin C Johnson; Kevin J Anderson; Elise T Courtois; Amit D Gujar; Floris P Barthel; Frederick S Varn; Diane Luo; Martine Seignon; Eunhee Yi; Hoon Kim; Marcos R H Estecio; Dacheng Zhao; Ming Tang; Nicholas E Navin; Rahul Maurya; Chew Yee Ngan; Niels Verburg; Philip C de Witt Hamer; Ketan Bulsara; Michael L Samuels; Sunit Das; Paul Robson; Roel G W Verhaak
Journal:  Nat Genet       Date:  2021-09-30       Impact factor: 41.307

Review 7.  Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC).

Authors:  Young Kwang Chae; Ayush Arya; Wade Iams; Marcelo R Cruz; Sunandana Chandra; Jaehyuk Choi; Francis Giles
Journal:  J Immunother Cancer       Date:  2018-05-16       Impact factor: 13.751

8.  Survival Analysis of Glioblastoma Multiforme

Authors:  Supapan Witthayanuwat; Montien Pesee; Chunsri Supaadirek; Narudom Supakalin; Komsan Thamronganantasakul; Srichai Krusun
Journal:  Asian Pac J Cancer Prev       Date:  2018-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.